These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 154937)

  • 1. Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover.
    Kuczenski R
    Brain Res; 1979 Mar; 164():217-25. PubMed ID: 154937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic effects of amphetamine on striatal dopamine dynamics.
    Kuczenski R
    Eur J Pharmacol; 1977 Dec; 46(3):249-57. PubMed ID: 590334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism.
    Kuczenski R
    J Pharmacol Exp Ther; 1980 Oct; 215(1):135-42. PubMed ID: 6109012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of striatonigral prodynorphin peptides by dopaminergic agents.
    Trujillo KA; Day R; Akil H
    Brain Res; 1990 Jun; 518(1-2):244-56. PubMed ID: 1975215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.
    Robinson TE; Becker JB
    Brain Res; 1986 Jun; 396(2):157-98. PubMed ID: 3527341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
    Jaskiw GE; Bongiovanni R
    Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
    Kuczenski R; Schmidt D; Leith N
    Brain Res; 1977 Apr; 126(1):117-29. PubMed ID: 558038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?
    Kuczenski R; Leith NJ
    Pharmacol Biochem Behav; 1981 Sep; 15(3):405-13. PubMed ID: 7291244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis.
    Becker JB; Cha JH
    Behav Brain Res; 1989 Nov; 35(2):117-25. PubMed ID: 2818831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
    Barnett JV; Kuczenski R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation.
    Conti LH; Segal DS; Kuczenski R
    Psychopharmacology (Berl); 1997 Mar; 130(2):183-8. PubMed ID: 9106917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats.
    Hillegaart V; Ahlenius S; Fowler CJ; Magnusson O
    Pharmacol Toxicol; 1988 Aug; 63(2):114-7. PubMed ID: 3186617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis study.
    Feigenbaum JJ; Howard SG
    Life Sci; 1997; 60(19):1659-68. PubMed ID: 9129121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons.
    Moore H; Todd CL; Grace AA
    J Neurosci; 1998 Jul; 18(13):5068-77. PubMed ID: 9634572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats.
    Miller DW; Abercrombie ED
    Brain Res Bull; 1996; 40(1):57-62. PubMed ID: 8722754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17β-Estradiol infusions into the dorsal striatum rapidly increase dorsal striatal dopamine release in vivo.
    Shams WM; Sanio C; Quinlan MG; Brake WG
    Neuroscience; 2016 Aug; 330():162-70. PubMed ID: 27256507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.